Cardiovascular Prevention and the Implementation Gap in GLP-1 Receptor Agonist Therapies: After the Trials

Scritto il 12/08/2026
da John Erhabor

No abstract

J Am Coll Cardiol. 2026 Aug 11;88(6):710-712. doi: 10.1016/j.jacc.2026.06.024.

NO ABSTRACT

PMID:42583991 | DOI:10.1016/j.jacc.2026.06.024